SCHEMBL19635228

SCHEMBL19635228

CC1CCC(n2nc(-c3ccc(CN4CCOCC4)cc3)c3c(N)ncnc32)CN1C#N

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 10/20 0.47
EGFR P00533 8/20 0.46
BTK Q06187 5/20 0.46
JAK3 P52333 3/20 0.46
LCK P06239 3/20 0.46
ITK Q08881 3/20 0.46
JAK2 O60674 2/20 0.46
JAK1 P23458 1/20 0.44
ERBB2 P04626 2/20 0.44
ERBB3 P21860 1/20 0.43
ERBB4 Q15303 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19635795 0.85 JAK3 (0.61) IGF1REGFRBTKJAK3LCK
SCHEMBL19635685 0.84 BTK (0.60) IGF1REGFRBTKJAK3LCK
SCHEMBL19635196 0.80 BTK (0.56) EGFRBTKLCKITK
SCHEMBL19635195 0.80 BTK (0.56) EGFRBTKLCKITK
SCHEMBL28370688 0.80 BTK (0.56) EGFRBTKLCKITK
SCHEMBL19635197 0.79 BTK (0.67) EGFRBTKLCKITK
SCHEMBL19635199 0.79 BTK (0.67) EGFRBTKLCKITK
SCHEMBL19635682 0.79 LCK (0.64) IGF1REGFRBTKJAK3LCK
SCHEMBL28370698 0.79 BTK (0.67) EGFRBTKLCKITK
SCHEMBL19635681 0.78 JAK3 (0.54) EGFRBTKJAK3LCKJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111153906-B Pyrazolopyrimidine derivatives as BTK inhibitors, process for their preparation and pharmaceutical compositions containing them 苏州信诺维医药科技有限公司 2020-09-11 CN disclosed
CN-111153906-A Pyrazolopyrimidine derivatives as BTK inhibitors, process for their preparation and pharmaceutical compositions containing them 苏州信诺维医药科技有限公司 2020-05-15 CN disclosed
CN-107383013-B Pyrazolopyrimidine derivatives as BTK inhibitors, process for their preparation and pharmaceutical compositions containing them 苏州信诺维医药科技有限公司 2020-03-31 CN disclosed
WO-2017198049-A1 PYRAZOLOPYRIMIDINE DERIVATIVE AS BTK INHIBITOR AND PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF 浙江予川医药科技有限公司 2017-11-23 WO disclosed